logo

For the Inventor, By the Inventor

Suffern, NY, United States of America

Adma S Ross

This inventor holds 10 USPTO granted patents. Top assignee: American Cyanamid Company. Active years: 1976-1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adma S Ross. Retrieved from https://idiyas.com/inventor/adma-s-ross

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 2.2

ph-index = 3

Forward Citations = 12(Granted Patents)


Company Filing History:

goldMedal10 out of 3,580 
 
American Cyanamid Company
 patents

Years Active: 1976-1990

Loading Chart...
10 patents (USPTO):Explore Patents
1. 4914091 - Esters of cephalosporin derivitives (1990-04-03),
2. 4404376 - Cephalosporanic acid derivatives (1983-09-13),
3. 4404375 - Cephalosporanic acid derivatives (1983-09-13),
4. 4404374 - Cephalosporanic acid derivatives (1983-09-13),
5. 4399132 - 7-Beta-[alpha-syn-methoxyimino-alpha-(2-aminothiazol-4-yl)-aceta (1983-08-16),
6. 4336375 - Cephalosporanic acid derivatives (1982-06-22),
7. 4159268 - 3-Chromonecarboxamido derivatives of penicillins (1979-06-26),
8. 4036849 - 1-(Para-substituted-phenyl)-1H-tetrazoles (1977-07-19),
9. 4010179 - 1-(Para-substituted-phenyl)-1H-tetrazoles (1977-03-01),
10. 3932440 - P-(1H-tetrazol-1-yl)-phenylcarbamates (1976-01-13),

Title: The Innovative Contributions of Adma S. Ross

Introduction

Adma S. Ross, an accomplished inventor from Suffern, NY, has made significant contributions to the field of pharmaceuticals, particularly through his development of cephalosporin derivatives. With a total of 10 patents to his name, Ross's work focuses on improving antibacterial treatments.

Latest Patents

Among his latest patents, Ross has disclosed innovative esters of cephalosporin derivatives, specifically the compound Adamantane 1 carbonyloxymethyl 7.beta.-[2-(2-aminothiazol-4-yl)-(Z)-2-methoxyiminoacetamido]-3-[(1,2,3-thiadiazol-5 yl)-thiomethyl]ceph-3-em-4 carboxylate. This compound, along with other esters, is designed for use as orally administered antibacterials, showcasing his commitment to advancing medical treatments. Additionally, his work on cephalosporanic acid derivatives, focusing on 7-acetamidocephalosporins, presents promising substitutions that enhance the effectiveness of the cephalosporin nucleus.

Career Highlights

Ross's career is marked by his position at the American Cyanamid Company, where he has been instrumental in developing groundbreaking pharmaceutical innovations. His ability to integrate complex chemical structures into practical antibacterial agents has garnered attention, making him a notable figure in the research community.

Collaborations

Throughout his career, Adma S. Ross has collaborated with talented individuals, including coworkers William V. Curran and Andrew S. Tomcufcik. These collaborations have led to successful innovations that benefit both the medical field and patients in need of effective antibiotic therapies.

Conclusion

Adma S. Ross exemplifies the spirit of innovation within the pharmaceutical industry. His numerous patents and collaborations demonstrate his dedication to advancing medical science and improving health outcomes. As he continues his work at the American Cyanamid Company, the impact of his contributions will likely resonate in the industry for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…